| Colorado                                       | 84-1028977                            |
|------------------------------------------------|---------------------------------------|
| (State                or other jurisdiction of | (I.R.S.                employer       |
| incorporation                or organization)  | identification                number) |

| c/o                Resource Management Partners, Inc.   |                      |
|---------------------------------------------------------|---------------------------|
| 1690                Washington Avenue                   |                      |
| Bohemia,                NY                              | 11716                     |
| (Address                of principal executive offices) | (Zip                Code) |

----

----

**MORLEX,      INC.**

**-      INDEX -**

| **PART                I - FINANCIAL INFORMATION:**                                                                  | Page   |
|---------------------------------------------------------------------------------------------------------------------|--------|
|                                                                                                                |   |
| Item                1. Unaduited Finanical Statements                                                               | 2      |
|                                                                                                                |   |
| Condensed                Balance Sheets as of March 31, 3006 and December 31, 2005                                  | 2      |
|                                                                                                                |   |
| Condensed                Statements of Operations for the Three Months ended March 31,                2006          | 3      |
| and                2005 and the Cumulative Period During the Development                Stage                       |   |
| (January                1, 2000 to March 31, 2006)                                                                  |   |
|                                                                                                                |   |
| Condensed                Statement of Changes in Shareholders’ Equity (Deficit) for the                Period | 4      |
| ended                March 31, 2006                                                                                 |   |
|                                                                                                                |   |
| Condensed                Statements of Cash Flows for the Three Months ended March 31,                2006          | 5      |
| and                2005 and the Cumulative Period During the Development                Stage                       |   |
| (January                1, 2000 to March 31, 2006)                                                                  |   |
|                                                                                                                |   |
| Notes                to Condensed Financial Statements                                                              | 6      |
|                                                                                                                |   |
| Item                2. Management's Discussion and Analysis or Plan of                Operation                     | 8      |
|                                                                                                                |   |
| Item                3. Controls and Procedures                                                                      | 8      |
|                                                                                                                |   |
| **PART                II - OTHER INFORMATION:**                                                                     |   |
|                                                                                                                |   |
| Item                1. Legal Proceedings                                                                            | 9      |
|                                                                                                                |   |
| Item                2. Unregistered Sales of Equity Securities and Use of                Proceeds                   | 9      |
|                                                                                                                |   |
| Item                3. Defaults Upon Senior Securities                                                              | 9      |
|                                                                                                                |   |
| Item                4. Submission of Matters to a Vote of Security Holders                                          | 9      |
|                                                                                                                |   |
| Item                5. Other Information                                                                            | 9      |
|                                                                                                                |   |
| Item                6. Exhibits and Reports on Form 8-K                                                             | 10     |
|                                                                                                                |   |
| Signatures                                                                                                          | 11     |
|                                                                                                                |   |
| Certifications                                                                                                      |   |

----

**PART      I - FINANCIAL INFORMATION**

**Item      1. Unaudited Financial Statements.**

**MORLEX,        INC.**

**(A        Development Stage Company)**

**CONDENSED        BALANCE SHEETS**

|                                                                              |   | **December                  31,** |     | **March                  31,** |   |
|-----------------------------------------------------------------------------------|--------|-----------------------------------|----------|--------------------------------|--------|
|                                                                              |   | **2005**                          |     | **2006**                       |   |
| **Assets**                                                                        |   |                              |     |                           |   |   |   |
| Current                  assets:                                                  |   |                              |     |                           |   |   |   |
| Cash                                                                              |   | $                                 | 91       |                           | $      | 255 |   |
| Other                  assets                                                     |   |                              |          |                           |   |  |   |
| Total                  assets                                                     |   | $                                 | 91       |                           | $      | 255 |   |
| **Liabilities                  and Stockholders' Equity (Deficit)**               |   |                              |     |                           |   |   |   |
| Current                  liabilities:                                             |   |                              |     |                           |   |   |   |
| Accrued                  expenses                                                 |   | $                                 | 15,388   |                           | $      | 8,680 |   |
| Total                  current liabilities                                        |   |                              | 15,388   |                           |   | 8,680 |   |
|                                                                              |   |                              |     |                           |   |   |   |
| Commitments                  and contingencies                                    |   |                              |     |                           |   |   |   |
|                                                                              |   |                              |     |                           |   |   |   |
| **Stockholders'                  Equity (Deficit)**                               |   |                              |     |                           |   |   |   |
| Common                  Stock, $0.001 par value; 1,000,000,000 shares authorized; |   |                              |     |                           |   |   |   |
| 971,765                  shares issued and outstanding as of March 31, 2006       |   |                              |     |                           |   |   |   |
| and                  December 31, 2005                                            |   |                              | 972      |                           |   | 972 |   |
| Receipts                  on account of shares to be allotted                     |   |                              | -        |                           |   | 8,000 |   |
| Additional                  paid-in capital                                       |   |                              | 399,798  |                           |   | 402,798 |   |
| Accumulated                  deficit                                              |   |                              | (341,027 | )                              |   | (341,027 | ) |
| Deficit                  accumulated during the development stage                 |   |                              | (74,818  | )                              |   | (78,946 | ) |
| Treasury                  stock, at per - 221,605 shares                          |   |                              | (222     | )                              |   | (222 | ) |
| Total                  stockholders' equity (deficit)                             |   |                              | (15,297  | )                              |   | (8,425 | ) |
|                                                                              |   |                              |     |                           |   |   |   |
| Total                  liabilities and stockholders' equity (deficit)             |   | $                                 | 91       |                           | $      | 255 |   |

----

**MORLEX,        INC.**

**(A        Development Stage Company)**

**CONDENSED        STATEMENTS OF OPERATIONS**

|                                                                  |   | **Three                  Months Ended March 31,** |    | **Cumulative                  During the Development Stage (January 1, 2000 to March 31,                  2006)** |   |
|-----------------------------------------------------------------------|--------|---------------------------------------------------|---------|-------------------------------------------------------------------------------------------------------------------|--------|
|                                                                  |   | **2005**                                          |    | **2006**                                                                                                          |   |   |   |
|                                                                  |   |                                              |    |                                                                                                              |   |   |   |
| Revenues                                                              |   | $                                                 | -       |                                                                                                              | $      | - |   | $ | - |   |
|                                                                  |   |                                              |    |                                                                                                              |   |   |   |   |   |   |
| Costs                  and expenses:                                  |   |                                              |    |                                                                                                              |   |   |   |   |   |   |
| Professional                  fees                                    |   |                                              | -       |                                                                                                              |   | 3,081 |   |   | 65,759 |   |
| Filing                  fees                                          |   |                                              | -       |                                                                                                              |   | 1,013 |   |   | 11,886 |   |
| Other                  expenses                                       |   |                                              | 30      |                                                                                                              |   | 34 |   |   | 1,301 |   |
| Total                  costs and expenses                             |   |                                              | 30      |                                                                                                              |   | 4,128 |   |   | 78,946 |   |
|                                                                  |   |                                              |    |                                                                                                              |   |   |   |   |   |   |
| Net                  loss                                             |   | $                                                 | (30     | )                                                                                                                 | $      | (4,128 | ) | $ | (78,946 | ) |
|                                                                  |   |                                              |    |                                                                                                              |   |   |   |   |   |   |
| Net                  loss per share - basic and diluted               |   | $                                                 | (0.00   | )                                                                                                                 | $      | (0.01 | ) | $ | (0.11 | ) |
|                                                                  |   |                                              |    |                                                                                                              |   |   |   |   |   |   |
| Weighted                  average number of common shares outstanding |   |                                              | 750,160 |                                                                                                              |   | 750,160 |   |   | 750,160 |   |

----

**MORLEX,        INC.**

**(A        Development Stage Company)**

**CONDENSED        STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT)**

**For        the period ended March 31, 2006**

|                                                          |   |    **Common                  Stock** |    | **Receipts                  on account of shares to be allotted** |   | **Additional                  Paid-In Capital** |   | **Accumulated                  Deficit** |   | **Deficit                  Accumulated During the Development Stage** |   | **Treasury                  Stock** |   | **Total                  Shareholders Equity (Deficit)** |     |
|---------------------------------------------------------------|--------|-----------------------------------------------------|---------|-------------------------------------------------------------------|--------|-------------------------------------------------|--------|------------------------------------------|--------|-----------------------------------------------------------------------|--------|-------------------------------------|--------|----------------------------------------------------------|----------|
|                                                          |   | **Number**                                          |    | **Amount**                                                        |   |
|                                                          |   |                                                |    |                                                              |   |                                            |   |                                     |   |                                                                  |   |                                |   |                                                     |     |   |   |
| **Balance                  at December 31, 2005**             |   |                                                | 971,765 |                                                              | $      | 972                                             |   |                                     |   |                                                                  | $      |  399,798                       |   | $                                                        | (341,027 | ) | $ | (74,818 | ) | $ | (222 | ) | $ | (15,297 | ) |
|                                                          |   |                                                |    |                                                              |   |                                            |   |                                     |   |                                                                  |   |                                |   |                                                     |     |   |   |   |   |   |   |   |   |   |   |
| Receipts                  on account of shares to be allotted |   |                                                |    |                                                              |   |                                            |   |                                     | 8,000  |                                                                  |   |                                |   |                                                     |     |   |   |   |   |   |   |   |   | 8,000 |   |
| Capital                  contributed                          |   |                                                | -       |                                                              |   | -                                               |   |                                     |   |                                                                  |   | 3,000                               |   |                                                     | -        |   |   | - |   |   | - |   |   | 3,000 |   |
| Net                  loss                                     |   |                                                | -       |                                                              |   | -                                               |   |                                     |   |                                                                  |   | -                                   |   |                                                     | -        |   |   | (4,128 | ) |   | - |   |   | (4,128 | ) |
|                                                          |   |                                                |    |                                                              |   |                                            |   |                                     |   |                                                                  |   |                                |   |                                                     |     |   |   |   |   |   |   |   |   |   |   |
| **Balance                  at March 31, 2006**                |   |                                                | 971,765 |                                                              | $      | 972                                             |   | $                                        | 8,000  |                                                                  | $      | 402,798                             |   | $                                                        | (341,027 | ) | $ | (78,946 | ) | $ | (222 | ) | $ | (8,425 | ) |

----

**MORLEX,        INC.**

**(A        Development Stage Company)**

**CONDENSED        STATEMENTS OF CASH FLOWS**

|                                                                       |   | **Three                  Months Ended March 31,** |   | **Cumulative                  During the Development Stage (January 1, 2000 to March 31,                  2006)** |   |
|----------------------------------------------------------------------------|--------|---------------------------------------------------|--------|-------------------------------------------------------------------------------------------------------------------|--------|
|                                                                       |   | **2005**                                          |   | **2006**                                                                                                          |   |   |   |
| **Operating                  activities**                                  |   |                                              |   |                                                                                                              |   |   |   |   |   |   |
| Net                  loss                                                  |   | $                                                 | (30    | )                                                                                                                 | $      | (4,128 | ) | $ | (78,946 | ) |
| Adjustments                  to reconcile net loss to net cash used        |   |                                              |   |                                                                                                              |   |   |   |   |   |   |
| in                  operating activities:                                  |   |                                              |   |                                                                                                              |   |   |   |   |   |   |
| Accrued                  expenses                                          |   |                                              | -      |                                                                                                              |   | (6,708 | ) |   | 7,200 |   |
|                                                                       |   |                                              |   |                                                                                                              |   |   |   |   |   |   |
| Net                  cash used in operating activities                     |   |                                              | (30    | )                                                                                                                 |   | (10,836 | ) |   | (71,746 | ) |
|                                                                       |   |                                              |   |                                                                                                              |   |   |   |   |   |   |
| **Financing                  activities**                                  |   |                                              |   |                                                                                                              |   |   |   |   |   |   |
| Receipts                  on account of shares to be allotted              |   |                                              | -      |                                                                                                              |   | 8,000 |   |   | 8,000 |   |
| Capital                  contributed                                       |   |                                              | -      |                                                                                                              |   | 3,000 |   |   | 60,900 |   |
|                                                                       |   |                                              |   |                                                                                                              |   |   |   |   |   |   |
| Net                  cash provided by financing activities                 |   |                                              | -      |                                                                                                              |   | 11,000 |   |   | 68,900 |   |
|                                                                       |   |                                              |   |                                                                                                              |   |   |   |   |   |   |
| Net                  increase (decrease) in cash and cash equivalents |   |                                              | (30    | )                                                                                                                 |   | 164 |   |   | (2,846 | ) |
|                                                                       |   |                                              |   |                                                                                                              |   |   |   |   |   |   |
| Cash                  at beginning of period                               |   |                                              | 2,291  |                                                                                                              |   | 91 |   |   | 3,101 |   |
|                                                                       |   |                                              |   |                                                                                                              |   |   |   |   |   |   |
| Cash                  at end of period                                     |   | $                                                 | 2,261  |                                                                                                              | $      | 255 |   | $ | 255 |   |

----

**MORLEX,        INC.**

**(A        Development Stage Company)**

**NOTES        TO CONDENSED FINANCIAL STATEMENTS**

**NOTE        1 - Description of the Company**

**NOTE        2 - Summary of Significant Accounting Policies**

**Basis        of Presentation**

**Use        of Estimates**

----

**MORLEX,        INC.**

**(A        Development Stage Company)**

**NOTES        TO CONDENSED FINANCIAL STATEMENTS - (Continued)**

**Net        Loss per Common Share**

**Fair        Value**

**NOTE        3 - Shareholders’ Equity**

**NOTE        4 - Income Taxes**

**NOTE        5 - Subsequent Events**

----

**Item      2. Management’s Discussion and Analysis or Plan of Operation.**

**Item      3. Controls and Procedures.**

----

**PART      II — OTHER INFORMATION**

**Item      1. Legal Proceedings. **

**Item      2. Unregistered Sales of Equity Securities and Use of Proceeds.**

**Item      3. Defaults Upon Senior Securities.**

**Item      4. Submission of Matters to a Vote of Security Holders.**

**Item      5. Other Information.**

----

**Item      6. Exhibits and Reports on 8-K.**

|  | Exhibit | Description |
|--|---------|-------------|

|  | *3.1 | Certificate                of Incorporation |
|--|------|---------------------------------------------|

|  | *3.2 | Amendment                to Certificate of Incorporation |
|--|------|----------------------------------------------------------|

|  | *3.3 | By-laws |
|--|------|---------|

|  | 31.1 | Certification                of the Company’s Principal Executive Officer and Principal Financial                Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002,                with                respect to the registrant’s Quarterly Report on Form 10-QSB for the period                ended March 31, 2006. |
|--|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 32.1 | Certification                of the Company’s Principal Executive Officer and Principal Financial                Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to                Section                906 of the Sarbanes Oxley Act of                2002. |
|--|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| * | Filed                as an exhibit to the Company's registration statement on Form 10-SB/A,                as                filed with                the Securities and Exchange Commission on November 8, 2005, and                incorporated herein                by this reference. |
|---|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

**SIGNATURES**

|                                |                          |                              |
|-------------------------------------|-------------------------------|-----------------------------------|
| Dated:                July 21, 2006 | MORLEX,                INC.   |
|                           |                     |                         |
|                                | By:                 | /s/                Donald Barrick |
|                                | Donald                Barrick |
|                                | President                     |

----